Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
81 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
82 Fine‑needle aspiration cytology versus core needle lymph node biopsy in axillary staging of breast cancer Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2022
83 Differential regulation of CD45 expression on granulocytes, lymphocytes, and monocytes in COVID-19 Department of Anesthesia, Intensive care and Pain management Mohammed gamal Thabet ahmed 2022
84 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Hanaan Ahmed Mohammed Ahmed 2022
85 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2022
86 Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022
87 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022
88 Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients Department of Cancer Biology Dr. Noha gaber sayed 2022
89 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2022
90 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2022